RDHL
RedHill Biopharma Ltd. Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website redhillbio.com
- Employees(FY) 113
- ISIN US7574682024
Performance
+3.41%
1W
+23.01%
1M
-13.98%
3M
+41.12%
6M
-67.56%
YTD
-78.76%
1Y
Profile
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Technical Analysis of RDHL 2024-05-10
Overview:
In analyzing the technical indicators for RDHL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2023-05-21 19:00
RedHill Provides R&D Update(Yahoo Finance)
- 2023-05-15 06:17
- 2023-05-08 19:00
- 2023-04-30 19:00
- 2023-04-27 19:00
- 2023-04-16 19:39
- 2023-04-10 19:00
- 2023-04-03 01:26
- 2023-03-29 20:00
- 2023-03-22 19:32
- 2023-03-20 19:00
- 2023-03-16 06:15
- 2023-03-08 06:05
- 2023-02-27 19:01
- 2023-02-27 18:00
- 2023-02-15 19:01
- 2023-02-15 19:00
- 2023-02-14 18:00
- 2023-02-10 02:10
- 2023-02-05 18:00
- 2023-01-25 18:00
- 2023-01-02 22:07
- 2023-01-02 18:00
- 2022-12-27 01:53
- 2022-12-06 20:45
- 2022-12-06 00:36
- 2022-12-01 20:00
- 2022-12-01 03:01
RedHill Biopharma Announces Proposed Public Offering(Yahoo Finance)
- 2022-11-28 19:00
- 2022-11-23 16:19